We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRN
3801
Amarin Corp
AMRN
$296M
$15.8K ﹤0.01%
971
+379
+64% +$4.26K
HCM icon
3802
HUTCHMED
HCM
$2.17B
$15.7K ﹤0.01%
1,042
+12
+1% +$175
STLN
3803
Starling Oncology, Inc. Common Stock
STLN
$632M
$15.7K ﹤0.01%
7,649
-1,894
-20% -$4.74K
HOWL icon
3804
Werewolf Therapeutics
HOWL
$18.6M
$15.7K ﹤0.01%
14,377
+5,235
+57% +$5.39K
NAUT icon
3805
Nautilus Biotechnolgy
NAUT
$113M
$15.6K ﹤0.01%
21,581
+10,827
+101% +$8.13K
EZPW icon
3806
Ezcorp Inc
EZPW
$1.66B
$15.6K ﹤0.01%
1,127
-6,067
-84% -$87.7K
TNYA icon
3807
Tenaya Therapeutics
TNYA
$168M
$15.6K ﹤0.01%
25,580
+2,850
+13% +$1.45K
GYRE icon
3808
Gyre Therapeutics
GYRE
$704M
$15.6K ﹤0.01%
2,124
+1,075
+102% +$9.38K
EWJ icon
3809
iShares MSCI Japan ETF
EWJ
$22.7B
$15.6K ﹤0.01%
208
+29
+16% +$2.06K
RSPM icon
3810
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$186M
$15.6K ﹤0.01%
480
-13,781
-97% -$430K
TTEC icon
3811
TTEC Holdings
TTEC
$84.2M
$15.5K ﹤0.01%
3,226
-123
-4% -$564
AL
3812
DELISTED
Air Lease Corp
AL
$15.5K ﹤0.01%
265
-1,379
-84% -$71.8K
VTGN icon
3813
VistaGen Therapeutics
VTGN
$11.9M
$15.4K ﹤0.01%
+7,721
New +$17.5K
BF.A icon
3814
Brown-Forman Class A
BF.A
$13B
$15.4K ﹤0.01%
561
-162
-22% -$5.2K
RAPT
3815
DELISTED
RAPT Therapeutics
RAPT
$15.3K ﹤0.01%
1,918
+171
+10% +$1.3K
PFF icon
3816
iShares Preferred and Income Securities ETF
PFF
$13.2B
$15.3K ﹤0.01%
500
+432
+635% +$13K
NOTE
3817
DELISTED
FiscalNote
NOTE
$15.3K ﹤0.01%
2,373
+1,394
+142% +$10.4K
DBI icon
3818
Designer Brands
DBI
$321M
$15.3K ﹤0.01%
6,414
+3,690
+135% +$11.1K
AFCG
3819
AFC Gamma
AFCG
$62.7M
$15.3K ﹤0.01%
3,405
+1,708
+101% +$8.79K
ARTV
3820
Artiva Biotherapeutics
ARTV
$576M
$15.2K ﹤0.01%
10,098
+7,484
+286% +$15.7K
SPEM icon
3821
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
$15.2K ﹤0.01%
+356
New +$14.4K
IGMS
3822
DELISTED
IGM Biosciences
IGMS
$15K ﹤0.01%
13,436
+6,217
+86% +$7.59K
FFAI
3823
Faraday Future Intelligent Electric
FFAI
$10.6M
$15K ﹤0.01%
60
+59
+5,900% +$10.8K
EWL icon
3824
iShares MSCI Switzerland ETF
EWL
$2.23B
$14.9K ﹤0.01%
272
+172
+172% +$9.19K
BW icon
3825
Babcock & Wilcox
BW
$1.37B
$14.9K ﹤0.01%
15,494
-3,226
-17% -$2.2K
151 152
153
154 155

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.